Pacira BioSciences, Inc. SEC filings PCRX
Pacira BioSciences, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Mar 31, 2014. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| SC 14D9/A | Filing | Nov 3, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2026 | — |
| SC 14D9 | Filing | Oct 30, 2026 | — |
| SC TO-T | Filing | Oct 30, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 13, 2026 | — |
| 4 | Insider transaction | Oct 9, 2026 | Oct 8, 2026 |
| SC TO-C | Filing | Oct 8, 2026 | — |
| SC14D9C | Filing | Oct 8, 2026 | — |
| 144 | Notice of proposed sale | Oct 8, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 8, 2026 | Oct 8, 2026 |
| SC TO-C | Filing | Oct 8, 2026 | — |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| S-8 | Employee stock plan registration | Aug 4, 2026 | — |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 30, 2026 | Jun 28, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 3 | Initial insider ownership | Jun 12, 2026 | Jun 9, 2026 |
| 144 | Notice of proposed sale | Jun 12, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 11, 2026 | Jun 9, 2026 |
| 144 | Notice of proposed sale | Jun 11, 2026 | — |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| DEFA14A | Additional proxy material | Jun 4, 2026 | — |
| 144 | Notice of proposed sale | Jun 4, 2026 | — |
| DEFA14A | Additional proxy material | Jun 1, 2026 | — |
| DFAN14A | Filing | May 28, 2026 | — |
| DEFA14A | Additional proxy material | May 28, 2026 | — |
| DEFA14A | Additional proxy material | May 27, 2026 | — |
| DEFA14A | Additional proxy material | May 26, 2026 | — |
| DFAN14A | Filing | May 21, 2026 | — |
| DEFA14A | Additional proxy material | May 20, 2026 | — |
| DFAN14A | Filing | May 20, 2026 | — |
| DEFA14A | Additional proxy material | May 20, 2026 | — |
| DEFA14A | Additional proxy material | May 13, 2026 | — |
| DFAN14A | Filing | May 13, 2026 | — |
| DEFC14A | Filing | May 12, 2026 | — |
| DFAN14A | Filing | May 12, 2026 | — |
| DEFA14A | Additional proxy material | May 12, 2026 | — |
| PRRN14A | Filing | May 8, 2026 | — |
| DEFA14A | Additional proxy material | May 5, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 1, 2026 | — |
| 10-Q | Quarterly report | Apr 30, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2026 | Apr 30, 2026 |
| PRRN14A | Filing | Apr 30, 2026 | — |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFC14A | Form defc14a | Apr 28, 2026 | — |
| 4 | Insider transaction | Apr 24, 2026 | Apr 23, 2026 |
| 144 | Notice of proposed sale | Apr 23, 2026 | — |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 144 | Notice of proposed sale | Apr 22, 2026 | — |
| 144 | Notice of proposed sale | Apr 21, 2026 | — |
| 144 | Notice of proposed sale | Apr 20, 2026 | — |
| PREC14A | Form- prec14a | Apr 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 9, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 4/A | Form 4/a | Mar 19, 2026 | Jun 11, 2025 |
| 4 | Insider transaction | Mar 19, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 19, 2026 | Mar 17, 2026 |
| 144 | Notice of proposed sale | Mar 17, 2026 | — |
| 144 | Notice of proposed sale | Mar 17, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 12, 2026 | — |
| DFAN14A | Filing | Mar 12, 2026 | — |
| DEFA14A | Additional proxy material | Mar 11, 2026 | — |
| DFAN14A | Filing | Mar 11, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 4 | Insider transaction | Jan 29, 2026 | Jan 27, 2026 |
| 3 | Initial insider ownership | Jan 29, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 28, 2026 | Jan 27, 2026 |
| DFAN14A | Amendment no. 1 | Jan 9, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Dec 31, 2025 |
| 144 | Notice of proposed sale | Jan 5, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 2, 2026 | — |
| DFAN14A | Filing | Dec 30, 2025 | — |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 144 | Notice of proposed sale | Dec 10, 2025 | — |
| 144 | Notice of proposed sale | Dec 9, 2025 | — |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| 4 | Insider transaction | Nov 13, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 10, 2025 | — |
| 144 | Notice of proposed sale | Nov 10, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 31, 2025 |
| 4 | Insider transaction | Sep 8, 2025 | Sep 4, 2025 |
| 144 | Notice of proposed sale | Sep 4, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 13, 2025 | — |
| 4 | Insider transaction | Aug 11, 2025 | Aug 7, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Aug 8, 2025 | — |
| 144 | Notice of proposed sale | Aug 7, 2025 | — |
| S-8 | Employee stock plan registration | Aug 5, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jul 10, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Jul 7, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 144 | Notice of proposed sale | Jun 4, 2025 | — |
| 144 | Notice of proposed sale | Jun 4, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 2, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 2, 2025 | — |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 10, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 28, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 22, 2025 | Apr 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 21, 2025 | — |
| DEFA14A | Additional proxy material | Apr 18, 2025 | — |
| DEFA14A | Additional proxy material | Apr 17, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 7, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 14, 2025 | Mar 12, 2025 |
| DEFA14A | Additional proxy material | Mar 14, 2025 | — |
| DFAN14A | Filing | Mar 14, 2025 | — |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 30, 2025 | Jan 28, 2025 |
| 3 | Initial insider ownership | Jan 28, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 21, 2025 | Jan 16, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 15, 2025 | — |
| 8-K |
Current report
Results of operations
|
Jan 10, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 144 | Notice of proposed sale | Jan 6, 2025 | — |
| 4 | Insider transaction | Dec 16, 2024 | Dec 13, 2024 |
| 144 | Notice of proposed sale | Dec 13, 2024 | — |
| DFAN14A | Filing | Dec 11, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 6, 2024 | Oct 31, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 21, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2024 | Sep 26, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 13, 2024 |
| 144 | Notice of proposed sale | Sep 13, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 9, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 16, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 16, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 12, 2024 |
| 4/A | Form 4/a | Aug 13, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 12, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Other events
|
Aug 9, 2024 | Aug 9, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PCRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1396814
- Former names
- Pacira Pharmaceuticals, Inc. (until Apr 9, 2019); PACIRA INC (until Nov 5, 2008); Blue Acquisition Corp (until Apr 16, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.